Edap Tms (NASDAQ:EDAP) versus Mindray Medical International (MR) Head-To-Head Analysis

Edap Tms (NASDAQ: EDAP) and Mindray Medical International (NYSE:MR) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability and institutional ownership.


Mindray Medical International pays an annual dividend of $0.36 per share and has a dividend yield of 1.3%. Edap Tms does not pay a dividend. Mindray Medical International pays out 24.2% of its earnings in the form of a dividend.


This table compares Edap Tms and Mindray Medical International’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Edap Tms -5.36% 7.85% 4.24%
Mindray Medical International 15.93% 12.70% 8.37%

Analyst Ratings

This is a summary of recent ratings and target prices for Edap Tms and Mindray Medical International, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Edap Tms 0 0 1 0 3.00
Mindray Medical International 0 0 0 0 N/A

Edap Tms currently has a consensus target price of $6.50, indicating a potential upside of 157.94%. Given Edap Tms’ higher possible upside, research analysts plainly believe Edap Tms is more favorable than Mindray Medical International.

Earnings and Valuation

This table compares Edap Tms and Mindray Medical International’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Edap Tms $39.28 million 1.86 $4.25 million ($0.08) -31.50
Mindray Medical International N/A N/A N/A $1.49 18.75

Edap Tms has higher revenue and earnings than Mindray Medical International. Edap Tms is trading at a lower price-to-earnings ratio than Mindray Medical International, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

9.2% of Edap Tms shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.


Mindray Medical International beats Edap Tms on 6 of the 11 factors compared between the two stocks.

About Edap Tms

EDAP TMS S.A. (EDAP) is a holding company engaged in developing and marketing the Ablatherm and Focal One devices. The Company operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The Company is developing HIFU technology for the treatment of certain other types of tumors. The Company also produces and commercializes medical equipment for treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL) and distributes other types of urology devices in certain countries. The HIFU division is engaged in the development, manufacturing and marketing of medical devices based on HIFU technology for the invasive treatment of urological and other clinical indications. The UDS division is engaged in the development, marketing, manufacturing and servicing of medical devices for the invasive diagnosis or treatment of urological disorders, urinary stones, and other clinical indications.

About Mindray Medical International

Mindray Medical International Limited is a developer, manufacturer and marketer of medical devices across the world. The Company operates in three segments: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. Its patient monitoring devices track the physiological parameters of patients, such as heart rate, blood pressure, respiration and temperature. It offers patient monitoring devices that are suitable for adult, pediatric and neonatal patients and are used principally in hospital intensive care units, operating rooms and emergency rooms. Its life support products provide operation room or intensive care unit solutions for the end users in the operating room. Its in-vitro diagnostic products provide data and analysis on blood, urine and other bodily fluid samples for clinical diagnosis and treatment. Its medical imaging systems segment includes ultrasound systems, digital radiography systems and a magnetic resonance imaging system.

Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply